News
Two New Lung Cancer Nonprofits Meet Critical Un...
Two exciting new lung cancer nonprofits are emerging to address critical gaps in support:Oncogene Cancer Research (OCR): This patient and family-driven organization advocates for and funds research specifically focused on...
Two New Lung Cancer Nonprofits Meet Critical Un...
Two exciting new lung cancer nonprofits are emerging to address critical gaps in support:Oncogene Cancer Research (OCR): This patient and family-driven organization advocates for and funds research specifically focused on...
ADC Drugs Offer Hope for RET+ NSCLC Patients
In case you missed it, one promising report from ASCO 2023 offers hope to patients who may be looking for additional options after RET-TKI's. Telisotuzumab vedotin (teliso-v) is a new...
ADC Drugs Offer Hope for RET+ NSCLC Patients
In case you missed it, one promising report from ASCO 2023 offers hope to patients who may be looking for additional options after RET-TKI's. Telisotuzumab vedotin (teliso-v) is a new...
Unlocking the Promise of RET Fusions: A Game-Ch...
Let's talk about RET, a fascinating receptor tyrosine kinase protein with a vital role in our development and cell growth. While it's normally beneficial, when RET signaling goes awry, it...
Unlocking the Promise of RET Fusions: A Game-Ch...
Let's talk about RET, a fascinating receptor tyrosine kinase protein with a vital role in our development and cell growth. While it's normally beneficial, when RET signaling goes awry, it...
RET Research Update: Encouraging Findings Ahead!
We have some exciting RET-specific research grant updates to share! RET-positive's science advisors, Hilary Hammell and Nicolas LeBel, recently met with our 2021 grant awardees and have painstakingly reviewed their research progress reports. Here's what they...
RET Research Update: Encouraging Findings Ahead!
We have some exciting RET-specific research grant updates to share! RET-positive's science advisors, Hilary Hammell and Nicolas LeBel, recently met with our 2021 grant awardees and have painstakingly reviewed their research progress reports. Here's what they...
Claim Denials? Don't Panic! Unlock the Power of...
Every US state has a DOI. Among other matters, it is their responsibility to help you: Understand your insurance policy File a complaint or appeal with your insurance company Identify...
Claim Denials? Don't Panic! Unlock the Power of...
Every US state has a DOI. Among other matters, it is their responsibility to help you: Understand your insurance policy File a complaint or appeal with your insurance company Identify...
Our interview with RETexpert Dr. Tejas Patil
RETpositive is excited to introduce you to Tejas Patil, Assistant Professor, Medicine-Medical Oncology, University of Colorado, School of Medicine. Dr. Patil is a 2022 Lungevity/Hamoui Foundation awardee for his research on MET and EGFR...
Our interview with RETexpert Dr. Tejas Patil
RETpositive is excited to introduce you to Tejas Patil, Assistant Professor, Medicine-Medical Oncology, University of Colorado, School of Medicine. Dr. Patil is a 2022 Lungevity/Hamoui Foundation awardee for his research on MET and EGFR...